Newcastle, DE, United States of America

Silvio Campagna

This inventor holds 3 USPTO granted patents. Top assignees: Dupont Pharmaceuticals Company, Other. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvio Campagna. Retrieved from https://idiyas.com/inventor/silvio-campagna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Silvio Campagna: Innovator in Metalloprotease Inhibitors

Introduction

Silvio Campagna is a notable inventor based in New Castle, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of metalloprotease inhibitors. With a total of 3 patents to his name, Campagna's work has had a meaningful impact on drug development.

Latest Patents

One of his latest patents is titled "Process for the preparation of macrocyclic metalloprotease inhibitors." This invention outlines a novel process for creating compounds that can effectively inhibit metalloproteases, which are enzymes that play a crucial role in various biological processes. The patent emphasizes the importance of these inhibitors in therapeutic applications.

Career Highlights

Throughout his career, Silvio Campagna has worked with prominent organizations, including DuPont Pharmaceuticals Company. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in drug development.

Collaborations

Campagna has collaborated with several professionals in his field, including Zhe Wang and Roberta L. Dorow. These partnerships have likely contributed to the success of his inventions and the advancement of research in metalloprotease inhibitors.

Conclusion

Silvio Campagna's contributions to the field of pharmaceuticals, particularly through his patents on metalloprotease inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…